학술논문
1371P First-line alectinib vs. brigatinib in advanced metastatic NSCLC with ALK rearrangement: Real-world data
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S787-S787
Subject
Language
ISSN
0923-7534